Transdermal scopolamine for reduction of drooling in developmentally delayed children.

scientific article published in June 1994

Transdermal scopolamine for reduction of drooling in developmentally delayed children. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID7516297

P2093author name stringLewis DW
Everett Y
Fontana C
Mehallick LK
P433issue6
P921main subjectL-scopolamineQ337188
P304page(s)484-486
P577publication date1994-06-01
P1433published inDevelopmental Medicine and Child NeurologyQ15716651
P1476titleTransdermal scopolamine for reduction of drooling in developmentally delayed children.
P478volume36

Reverse relations

cites work (P2860)
Q33634069A search for the evidence supporting community paediatric practice
Q35538621A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling
Q43094424Amyotrophic lateral sclerosis: management of bulbar symptoms
Q35613311Amyotrophic lateral sclerosis: update for family physicians
Q38628153Comparative study of hyoscine doses as antisialagogue for patients receiving ketofol sedation undergoing colonoscopy procedures
Q39244054Drooling in children
Q99563458Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital
Q37516494Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments
Q33906343Management of drooling in disabled patients with scopolamine patches.
Q80852665Management of symptoms in amyotrophic lateral sclerosis
Q46023087Respiratory Failure or Impairment in Amyotrophic Lateral Sclerosis.
Q34529525Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications

Search more.